Browsing Category

44027 posts

One Year In, Drunk Angel Defines Its Distinctive Approach to Crystal Jewelry

NEW YORK, Sept. 8, 2026 /PRNewswire/ — One year after establishing its…

ClubMed Lifestyle Group Advances Global Expansion Through Industry Collaboration and AI Application

HONG KONG, Sept. 8, 2026 /PRNewswire/ — ClubMed Lifestyle Group, a subsidiary…
As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen

As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen

Kolmar Korea advances K-sun care with non-menthol cooling ingredients, water-drop technology, and…
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of .7 Billion

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of $15.7 Billion

Bitmine owns 4.9% of the total ETH coin supply of 122.0 million…

Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo

NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ — Accro Bioscience…

HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the…

Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy

SHANGHAI, Sept. 8, 2026 /PRNewswire/ — Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or…

Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the…